Literature DB >> 4047730

Prognostic histopathological factors in malignant melanoma.

H M Shaw, C M Balch, S J Soong, G W Milton, W H McCarthy.   

Abstract

An analysis of prognostic factors in 4000 patients with cutaneous malignant melanoma at the Sydney Melanoma Unit and the University of Alabama in Birmingham has demonstrated that the histological features of the primary melanoma become less predictive of survival the more advanced the disease becomes. Thus, whilst 4 features of primary lesions were independent predictors in localized disease (tumour thickness, ulceration, level of invasion and regression), only one of the stronger ones (ulceration) remained predictive in patients with regional lymph node metastases. Once distant spread was evident, there were no parameters of the primary lesion that predicted survival. Thus, in patients with advanced disease prognosis was dictated by the extent of metastatic involvement: the number of positive lymph nodes in stage II patients and the number and location of metastatic sites in stage III patients.

Entities:  

Mesh:

Year:  1985        PMID: 4047730     DOI: 10.3109/00313028509063766

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  10 in total

1.  Missed malignant melanomas.

Authors:  L G Gordon; W S Lowry
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

2.  Tumor thickness is not a prognostic factor in thin melanoma.

Authors:  S K Jones; P V Pocock; J C Briggs
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

3.  Tumor thickness is not a prognostic factor in thin melanoma.

Authors:  C Kuehnl-Petzoldt; S Fischer
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 4.  Staging and prognosis of cutaneous melanoma.

Authors:  Paxton V Dickson; Jeffrey E Gershenwald
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

Review 5.  Temozolomide for treatment of brain metastases: A review of 21 clinical trials.

Authors:  Wei Zhu; Li Zhou; Jia-Qi Qian; Tian-Zhu Qiu; Yong-Qian Shu; Ping Liu
Journal:  World J Clin Oncol       Date:  2014-02-10

6.  Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA).

Authors:  A B Gelb; B R Smoller; R A Warnke; L J Picker
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Evaluation of aid to diagnosis of pigmented skin lesions in general practice: controlled trial randomised by practice.

Authors:  Dallas R English; Robert C Burton; Chris B del Mar; Robert J Donovan; Paul D Ireland; Geoff Emery
Journal:  BMJ       Date:  2003-08-16

8.  Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.

Authors:  R A Williams; J Rode; A P Dhillon; L R Jarvis; J M Skinner; O Jamal
Journal:  J Clin Pathol       Date:  1986-10       Impact factor: 3.411

9.  Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.

Authors:  N H Cox; T C Aitchison; J M Sirel; R M MacKie
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

10.  Analysis of the Clinical and Histopathological Patterns of 100 Consecutive Cases of Primary Cutaneous Melanoma and Correlation with Staging.

Authors:  Kyung Wook Nam; Yong Chan Bae; Seong Hwan Bae; Kyung Ho Song; Hoon Soo Kim; Young Jin Choi
Journal:  Arch Plast Surg       Date:  2015-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.